Joseph P Lyssikatos insider trades
Open-market stock purchases and sales by Joseph P Lyssikatos, CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc, from SEC Form 4 filings since Feb 23, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc | Bought (not open market) | — |
| Feb 6, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $145K |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $390K |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $145K |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $1M |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $1.5M |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $151K |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc | Sold | $842K |
| Dec 19, 2025 | ELVN Enliven Therapeutics, Inc | Sold | $84.2K |
| Nov 19, 2025 | ELVN Enliven Therapeutics, Inc | Sold | $268K |
| Nov 19, 2025 | ELVN Enliven Therapeutics, Inc | Sold | $11.4K |
| Oct 20, 2025 | ELVN Enliven Therapeutics, Inc | Sold | $276K |
Companies traded
- ELVN Enliven Therapeutics, Inc: 60 sales, last Feb 12, 2026
Get free alerts when Joseph P Lyssikatos files a new trade →